An Ethical Imperative
Effective pain management for laboratory animals is an essential need in today’s research institutions.
Leading laboratory associations, including the Office of Laboratory Animal Welfare (OLAW), increasingly recognize the ethical and scientific importance of using the highest-quality analgesics available to protect the welfare of laboratory animals and limit variability in research results.
Fidelis Pharmaceuticals is a commercial stage company with a product platform focused on fulfilling unmet needs for pharmaceutical-grade pain management for laboratory animals and additional species:
Important Safety Information
For Rats and Mice:
Only administer Ethiqa XR by subcutaneous injection. Ethiqa XR is not intended for intravenous, intra-arterial, intrathecal, intramuscular, or intra-peritoneal injection. Do not use on mice or rats with pre-existing respiratory deficiencies. Do not keep rats on wood chip-type bedding after administration of Ethiqa XR. Use caution with concomitant administration of Ethiqa XR with drugs that cause respiratory depression.
Ethiqa XR should only be administered by a veterinarian or laboratory staff trained in the handling of potent opioids. Protective clothing is recommended to avoid direct contact with human skin or mucus membranes which could result in absorption of buprenorphine and adverse reactions. Not for use in humans.